CAS: 36798-79-5 - Budralazine
Fórmula:C14H16N4
InChI:InChI=1S/C14H16N4/c1-10(2)8-11(3)16-18-14-13-7-5-4-6-12(13)9-15-17-14/h4-9H,1-3H3,(H,17,18)
Chave InChI:InChIKey=DQGFCLJXYFXXIJ-UHFFFAOYSA-N
SMILES:N=1N=C(NN=C(C=C(C)C)C)C=2C=CC=CC2C1
- Sinónimos:
- 1(2H)-Phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazone
- 1-(2-(1,3-Dimethyl-2-Butenylidene)Hydrazino)Phthalazine
- 1-[(2E)-2-(1,3-dimethylbut-2-en-1-ylidene)hydrazino]phthalazine
- 1-[2-(1,3-Dimethyl-2-buten-1-ylidene)hydrazino]phthalazine
- 1-[2-(4-Methylpent-3-En-2-Ylidene)Hydrazinyl]Phthalazine
- 3-Penten-2-one, 4-methyl-, 2-(1-phthalazinyl)hydrazone
- Buterazine
- Dj 1461
- Budralazine
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Budralazine REF: TR-B689515CAS: 36798-79-5 | - - - | 330,00 €~2.139,00 € | Ter 21 Jan 25 | |
Budralazine REF: TM-T23834CAS: 36798-79-5 | 98% | 908,00 €~2.338,00 € | Qua 29 Jan 25 | |
Budralazine REF: 3D-LBA79879CAS: 36798-79-5 | Min. 95% | 95,00 €~740,00 € | Qua 05 Fev 25 |
Budralazine
Produto ControladoCAS:36798-79-5
Applications Budralazine a new antihypertensive agent. Budralazine is a direct-acting vasodilator. References Moroi, R. et …
Fórmula:
C14H16N4
Cor e Forma:
Neat
Peso molecular:
240.30
Ref: TR-B689515
50mg | 330,00 € | ||
500mg | 2.139,00 € |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
Budralazine
CAS:36798-79-5
Budralazine is an agent of antihypertensive drug.
Fórmula:
C14H16N4
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
240.3
Ref: TM-T23834
25mg | 1.410,00 € | ||
50mg | 1.852,00 € | ||
100mg | 2.338,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 29 de Janeiro de 2025
Budralazine
CAS:36798-79-5
Budralazine is an inhibitor of the enzyme phosphofructokinase, which is responsible for the conversion of …
Fórmula:
C14H16N4
Pureza:
Min. 95%
Peso molecular:
240.3 g/mol
Ref: 3D-LBA79879
2mg | 172,00 € | ||
5mg | 248,00 € | ||
10mg | 364,00 € | ||
25mg | 518,00 € | ||
50mg | 740,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 5 de Fevereiro de 2025